CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.1100
0.00 (0.00%)
Aug 25, 2025, 9:30 AM EDT
CS Diagnostics Market Cap
CS Diagnostics has a market cap or net worth of $13.73 million as of August 27, 2025. Its market cap has decreased by -61.59% in one year.
Market Cap
13.73M
Enterprise Value
13.68M
Revenue
128.07K
Ranking
n/a
PE Ratio
566.02
Stock Price
$0.11
Market Cap Chart
Since March 31, 2016, CS Diagnostics's market cap has increased from 738.94K to 13.73M, an increase of 1,758.62%. That is a compound annual growth rate of 36.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 13.73M | -90.88% |
| Dec 31, 2024 | 150.56M | 38,005.96% |
| Dec 29, 2023 | 395.10K | -47.85% |
| Dec 23, 2022 | 757.61K | 5,499.87% |
| Dec 31, 2021 | 13.53K | -98.46% |
| Dec 31, 2020 | 879.37K | 16.07% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |